Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.37 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.37 |
| ▸ | FYN | P06241 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | AHR | P35869 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.32 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | NQO1 | P15559 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31529058 | 0.79 | ALDH1A1 (0.52) | HPGDALDH1A1HSD17B10CYP3A4TSHR | |
| SCHEMBL442152 | 0.79 | ALDH1A1 (0.52) | HPGDALDH1A1HSD17B10CYP3A4TSHR | |
| SCHEMBL444099 | 0.77 | ALDH1A1 (0.50) | HPGDALDH1A1HSD17B10CYP3A4TSHR | |
| SCHEMBL443084 | 0.74 | CYP1A2 (0.46) | HPGDALDH1A1HSD17B10CYP3A4TSHR | |
| SCHEMBL277160 | 0.74 | ALDH1A1 (0.42) | HPGDALDH1A1HSD17B10CYP3A4TSHR | |
| SCHEMBL276465 | 0.73 | ALDH1A1 (0.41) | HPGDALDH1A1HSD17B10CYP3A4TSHR | |
| SCHEMBL12627452 | 0.68 | ALDH1A1 (0.46) | HPGDALDH1A1HSD17B10CYP3A4TSHR | |
| SCHEMBL2351815 | 0.68 | HPGD (0.54) | HPGDALDH1A1HSD17B10CYP3A4TSHR | |
| SCHEMBL16574516 | 0.68 | LTA4H (0.46) | HPGDALDH1A1HSD17B10CYP3A4TSHR | |
| SCHEMBL14101036 | 0.68 | ALDH1A1 (0.42) | HPGDALDH1A1HSD17B10TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2116521-B1 | PROCESS FOR PRODUCING FULLERENE DERIVATIVE | JAPAN SCIENCE & TECH AGENCY (JP) | 2016-07-06 | — | — | EP | disclosed |
| US-8134019-B2 | Process for producing fullerene derivative | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2012-03-13 | — | — | US | disclosed |
| US-20100048934-A1 | PROCESS FOR PRODUCING FULLERENE DERIVATIVE | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2010-02-25 | — | — | US | disclosed |
| EP-2116521-A1 | PROCESS FOR PRODUCING FULLERENE DERIVATIVE | Japan Science and Technology Agency (JP) | 2009-11-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048934-A1 | PROCESS FOR PRODUCING FULLERENE DERIVATIVE | INF2, EIF4B, C9 | HPGD 3132/4885ALDH1A1 1723/4885HSD17B10 1514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.